Conference Activities & Talks -

Division display  301 - 320 of about 331 ／  All the affair displays >>

  1. Kyoko Ohno-Matsui. Key Note Speech - What is the fundamental nature of PM? – a short excursion into histology, morphology and 3D anatomy.. 2nd international conference of pathologic myopia (iPM) 2015.06.19 Kyoto, Japan

  2. Kyoko Ohno-Matsui. Myopic maculopathy-update on its understanding and management.. Update on high myopia and its associated disease. 2015.06.13 Taipei, Taiwan

  3. Kyoko Ohno-Matsui. Optic Disc Shape and Visual Field Defects in Eyes with Pathologic Myopia.. World Glaucoma Congress 2015 2015.06.09 Hong Kong, China

  4. Kyoko Ohno-Matsui. Updates on Myopic CNV. SNEC 25th ANNIVERSARY INTERNATIONAL MEETING 2015.05.22 SINGAPORE

  5. Kyoko Ohno-Matsui. Imaging & Management Decisions in Complications Associated with Pathological Myopia. SNEC 25th ANNIVERSARY INTERNATIONAL MEETING 2015.05.22 SINGAPORE

  6. Kyoko Ohno-Matsui. Lamina Cribrosa Changes in Myopia: Implications in Glaucoma Diagnosis and Monitoring. 30th APAO(Asia-Pacific Academy of Ophthalmology) 2015.04.04

  7. Kyoko Ohno-Matsui. Wide-Field Fundus Imaging of Pathologic Myopia. 30th APAO(Asia-Pacific Academy of Ophthalmology) 2015.04.02 Guangzhou, China

  8. Kyoko Ohno-Matsui. Visual Outcomes in Patients with Myopic Choroidal Neovascularisation Receiving Intravitreal Aflibercept Injection. 30th APAO(Asia-Pacific Academy of Ophthalmology) 2015.04.02 Guangzhou, China

  9. Kyoko Ohno-Matsui. Pathological Consequences of High Myopia. 30th APAO(Asia-Pacific Academy of Ophthalmology) 2015.04.01 Guangzhou, China

  10. Kyoko Ohno-Matsui. Imaging of the Highly Myopic Optic Nerve Head. 30th APAO(Asia-Pacific Academy of Ophthalmology) 2015.03.31 Guangzhou, China

  11. Kyoko Ohno-Matsui. Terminology and classification of pathologic myopia. . WHO-BHVI joint Global Scientific Meeting on Myopia 2015.03.06 Sydney, Australia

  12. Tomoka Ishida, Takeshi Yoshida, Kosei Shinohara, Liu Hongding, Kyoko Ohno-Matsui.. The role of sirt1 for egulating VEGF in human RPE. Asia－ARVO 2015 2015.02.17

  13. Kyoko Ohno-Matsui. Prognostic Factors for Visual Outcomes in Choroidal Neovascularisation Secondary to Pathological Myopia (Myopic CNV). AAO(American Academy of Ophthalmology) 2014 2014.10.20 Chicago, USA

  14. Paolo Nucci, Francesco Pichi, Antonio P Ciardella, Kyoko Ohno-Matsui . Spectral Domain OCT Findings in Pediatric Tilted Disc Syndrome. AAO(American Academy of Ophthalmology) 2014 2014.10.19 Chicago, USA

  15. Sonya Liang, Noriaki Shimada, Natsuko Nagaoka, Kosei Shinohara, Kyoko Ohno-Matsui. Analyses of dome-shaped macula in a large population of the patients with pathologic myopia. AAO(American Academy of Ophthalmology) 2014 2014.10.19 Chicago, USA

  16. Tien Yin Wong, Paolo Lanzetta, Nikol Heinrichs, Stefan Pilz, Kyoko Ohno-Matsui. Ranibizumab in patients with visual impairment due to myopic choroidal neovascularization : A subgroup analysis of East Asian and Caucasian patients from the RADIANCE study. 14th EURETINA Congress 2014.09.11 London, UK

  17. Kyoko Ohno-Matsui. Ranibizumab: compelling evidence and clear guidance in myopic CNV management. 14th EURETINA Congress 2014.09.11 London, UK

  18. Kyoko Ohno-Matsui.. Treatment of Myopic CNV. Treatment of Myopic CNV 2014.07.20 Taipei, TAIWAN

  19. Kyoko Ohno-Matsui. Posterior Staphyroma. International conference of pathologic myopia (iPM) 2014.07.19 Taipei, TAIWAN

  20. Lai T, Ohno-Matsui K, Tien WY, Lanzetta P, Stefan P, Nikol H. Comparison of visual acuity outcomes and ranibizumab treatment exposure in East-Asian and Caucasian patients with visual impairment due to myopic CNV: a RADIANCE study subgroup analysis. The Association for Research in Vision and Ophthalmology. ARVO 2014 Annual Meeting 2014.05.05 USA

< PREV - NEXT >

To the head of this page.▲